Maintate Side Effects

Common Maintate Side Effects

The most commonly reported Maintate side effects (click to view or check a box to report):

Interstitial Lung Disease (2)
Treatment Noncompliance (1)
Thrombocytopenia (1)
Syncope (1)
Urticaria (1)
Hepatic Function Abnormal (1)
Cataract (1)
Low Density Lipoprotein Increased (1)
Liver Disorder (1)
Swelling (1)
Nephrogenic Anaemia (1)
Oedema Peripheral (1)
Nodal Rhythm (1)
Blood Creatinine Increased (1)
Oliguria (1)
Blood Pressure Diastolic Decreased (1)
Bradycardia (1)
Blood Pressure Systolic Increased (1)
Blood Pressure Increased (1)
Megakaryocytes Decreased (1)

➢ More

If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Maintate Side Effects Reported to FDA

The following Maintate reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.

The appearance of Maintate on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Interstitial Lung Disease
This is a report of a 71-year-old female patient (weight: NA) from JP, suffering from the following symptoms/conditions: supraventricular extrasystoles, who was treated with Maintate (dosage: NA, start time: May 09, 2012), combined with:
  • Bufferin 81mg
  • Gaslon N
  • Gasmotin
  • Simponi
  • Natrix
  • Diovan
  • Norvasc
  • Sunrythm
and developed a serious reaction and side effect(s). The consumer presented with:
  • Interstitial Lung Disease
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Maintate treatment in female patients, resulting in interstitial lung disease side effect. The patient was hospitalized.

Diabetic Nephropathy, Blood Pressure Systolic Increased, Glycosylated Haemoglobin Increased, Urticaria, Blood Pressure Diastolic Decreased, Nephrogenic Anaemia, Swelling, Oedema Peripheral, Cough
This report suggests a potential Maintate Diabetic Nephropathy, Blood Pressure Systolic Increased, Glycosylated Haemoglobin Increased, Urticaria, Blood Pressure Diastolic Decreased, Nephrogenic Anaemia, Swelling, Oedema Peripheral, Cough side effect(s) that can have serious consequences. A female patient (weight: NA) from JAPAN was diagnosed with the following symptoms/conditions: hypertension and used Maintate (dosage: 2.5 Mg, Unk) starting Aug 06, 2008. Soon after starting Maintate the patient began experiencing various side effects, including:
  • Diabetic Nephropathy
  • Blood Pressure Systolic Increased
  • Glycosylated Haemoglobin Increased
  • Urticaria
  • Blood Pressure Diastolic Decreased
  • Nephrogenic Anaemia
  • Swelling
  • Oedema Peripheral
  • Cough
Drugs used concurrently:
  • Novorapid (46 Iu, Unk)
  • Zetia (10 Mg, Unk)
  • Artist (Unk)
  • Valsartan (80 Mg Per Day)
  • Lantus (32 Iu Daily)
  • Diart (30 Mg, Unk)
  • Benecid (500 Mg, Unk)
  • Lipitor (20 Mg, Unk)
The patient was hospitalized. Although Maintate demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as diabetic nephropathy, may still occur.

This Syncope problem was reported by a physician from JAPAN. A 66-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: hypertension,rhinitis allergic. On Mar 06, 2007 this consumer started treatment with Maintate (dosage: NA). The following drugs were being taken at the same time:
  • Fexofenadine Hcl (Dose Unit: 60 Mg)
  • Sinlestal
  • Gaster D (Dose Unit: 10 Mg)
When commencing Maintate, the patient experienced the following unwanted symptoms/side effects:
  • Syncope
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as syncope, may become evident only after a product is in use by the general population.

Interstitial Lung Disease, Low Density Lipoprotein Increased, Cataract
This is a report of a 80-year-old female patient (weight: NA) from JAPAN. The patient developed the following symptoms/conditions: NA and was treated with Maintate (dosage: Unk) starting NS. Concurrently used drugs:
  • Bufferin (81 Mg, Unk)
  • Lochol (30 Mg, Daily)
Soon after that, the consumer experienced the following side effects:
  • Interstitial Lung Disease
  • Low Density Lipoprotein Increased
  • Cataract
The patient was hospitalized. This opens a possibility that Maintate treatment could cause the above reactions, including interstitial lung disease, and some female subjects may be more susceptible.

Hepatic Function Abnormal
A 88-year-old female patient (weight: NA) from JAPAN with the following symptoms/conditions: NA started Maintate treatment (dosage: Unk) on Sep 17, 2010. Soon after starting Maintate treatment, the subject experienced various side effects, including:
  • Hepatic Function Abnormal
Concurrently used drugs:
  • Lipitor (10 Mg, 1x/day)
  • Gaster (20 Mg, 1x/day)
  • Thyradin S (Unk)
  • Risedronate Sodium (Unk)
  • Pletal (400 Mg, 1x/day)
  • Senevacul (Unk)
  • Selbex (Unk)
  • Predonine (Unk)
The patient was hospitalized. This finding indicates that some female patients could be more vulnerable to Maintate.

Liver Disorder
A 62-year-old female patient from JAPAN (weight: NA) experienced symptoms, such as: NA and was treated with Maintate (bisoprolol Fumarate)(dosage: Daily Dose). The treatment was initiated on Jun 01, 2007. After that a consumer reported the following side effect(s):
  • Liver Disorder
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Maintate (bisoprolol Fumarate) efficacy: NA.

Blood Creatinine Increased, Continuous Haemodiafiltration, Oliguria, Pleural Effusion, Pulmonary Congestion, Renal Failure, Shock, Somnolence
In this report, Maintate (bisoprlol Fumarate) was administered for the following condition: NA.A 39-year-old male consumer from JAPAN (weight: NA) started Maintate (bisoprlol Fumarate) treatment (dosage: 150 Mg (150 Mg, 1 In 1 D)) on NS.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Blood Creatinine Increased
  • Continuous Haemodiafiltration
  • Oliguria
  • Pleural Effusion
  • Pulmonary Congestion
  • Renal Failure
  • Shock
  • Somnolence
A possible interaction with other drugs could have contributed to this reaction:
  • Amlodipine (850 Mg (850 Mg, 1 In 1 D))
The patient was hospitalized.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Maintate (bisoprlol Fumarate) treatment could be related to the listed above side effect(s).

Anti-platelet Antibody Positive, Bleeding Time Prolonged, Blood Pressure Increased, Epistaxis, Haemoptysis, Haemorrhage Subcutaneous, Megakaryocytes Decreased, Platelet Count Decreased, Thrombocytopenia
This is a report of the following Maintate side effect(s):
  • Anti-platelet Antibody Positive
  • Bleeding Time Prolonged
  • Blood Pressure Increased
  • Epistaxis
  • Haemoptysis
  • Haemorrhage Subcutaneous
  • Megakaryocytes Decreased
  • Platelet Count Decreased
  • Thrombocytopenia
A 68-year-old female patient from JAPAN (weight: NA) presented with the following condition: hypertension,lipids abnormal and received a treatment with Maintate (dosage: 2.5 Mg/day) starting: Jun 01, 2005.The following concurrently used drugs could have generated interactions:
  • Fluvastatin (30mg/day)
  • Norvasc (5mg/day)
  • Aspirin (100mg/day)
  • Diovan (160 Mg/day)
  • Depas (1 Mg/day)
The patient was hospitalized.This report suggests that a Maintate treatment could be associated with the listed above side effect(s).

Atrial Fibrillation, Bradycardia, Disease Recurrence, Fall, Nodal Rhythm, Sinus Arrest, Treatment Noncompliance
This Maintate (tablet) (bisoprolol Fumarate) report was submitted by a 56-year-old female consumer from (weight: NA). The patient was diagnosed with: atrial fibrillation,hypertension and Maintate (tablet) (bisoprolol Fumarate) was administered (dosage: 2.5 Mg (2,5 Mg, 1 In 1 D), Oral) starting: May 10, 2005. The consumer developed a set of symptoms:
  • Atrial Fibrillation
  • Bradycardia
  • Disease Recurrence
  • Fall
  • Nodal Rhythm
  • Sinus Arrest
  • Treatment Noncompliance
Other drugs used simultaneously: NA.The patient was hospitalized.Those unexpected symptoms could be linked to a Maintate (tablet) (bisoprolol Fumarate) treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    Discuss Maintate Side Effects

    Did You Have a Maintate Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor

    How Effective is Maintate for You?

    Exceeded Expectations
    Somewhat Effective
    Not Effective

    Maintate Safety Alerts, Active Ingredients, Usage Information

    More About Maintate

    Side Effects reported to FDA: 9

    Maintate safety alerts: No

    Reported hospitalizations: 5

    Latest Maintate clinical trials

    Maintate Reviews

    No reviews, be a first to report a side effect via side effect reporting form